PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
21.72
+0.81 (3.87%)
At close: Jun 18, 2026, 4:00 PM EDT
21.82
+0.10 (0.46%)
After-hours: Jun 18, 2026, 7:48 PM EDT
PROCEPT BioRobotics Market Cap
PROCEPT BioRobotics has a market cap or net worth of $1.24 billion as of June 18, 2026. Its market cap has decreased by -63.74% in one year.
Market Cap
1.24B
Enterprise Value
1.07B
1-Year Change
-63.74%
Ranking
Category
Stock Price
$21.72
Market Cap Chart
Since the IPO on September 15, 2021, PROCEPT BioRobotics's market cap has increased from $1.06B to $1.24B, an increase of 16.99%. That is a compound annual growth rate of 3.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.24B | -29.67% |
| Dec 31, 2025 | 1.76B | -59.65% |
| Dec 31, 2024 | 4.36B | 105.85% |
| Dec 29, 2023 | 2.12B | 13.93% |
| Dec 30, 2022 | 1.86B | 70.76% |
| Dec 31, 2021 | 1.09B | 2.94% |
| Sep 15, 2021 | 1.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integra LifeSciences Holdings | 1.37B |
| Alphatec Holdings | 1.35B |
| AdaptHealth | 1.28B |
| Enovis | 1.26B |
| Inspire Medical Systems | 1.23B |
| IRADIMED CORPORATION | 1.18B |
| Avanos Medical | 1.17B |
| Tandem Diabetes Care | 1.05B |